Ehsan Razeghian

766 total citations · 1 hit paper
10 papers, 462 citations indexed

About

Ehsan Razeghian is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ehsan Razeghian has authored 10 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ehsan Razeghian's work include CRISPR and Genetic Engineering (3 papers), CAR-T cell therapy research (3 papers) and Pluripotent Stem Cells Research (2 papers). Ehsan Razeghian is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), CAR-T cell therapy research (3 papers) and Pluripotent Stem Cells Research (2 papers). Ehsan Razeghian collaborates with scholars based in Iran, Iraq and Russia. Ehsan Razeghian's co-authors include Wanich Suksatan, Lakshmi Thangavelu, Ahmed Raji, Mohammed Nader Shalaby, Adel Naimi, Alexei Valerievich Yumashev, Ali Noroozi‐Aghideh, Supat Chupradit, Rebar N. Mohammed and Ali Adili and has published in prestigious journals such as Stem Cell Research & Therapy, International Immunopharmacology and Cell Communication and Signaling.

In The Last Decade

Ehsan Razeghian

10 papers receiving 459 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

2022 306 citations Adel Naimi, Rebar N. Mohammed et al. Cell Communication and Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ehsan Razeghian Iran	6	282	168	163	71	51	10	462
Brian M. Olson United States	9	321 1.1×	167 1.0×	308 1.9×	95 1.3×	67 1.3×	27	590
Cassandra E. Burnett United States	6	225 0.8×	130 0.8×	209 1.3×	31 0.4×	71 1.4×	9	451
Dylan T. Ammons United States	6	279 1.0×	131 0.8×	294 1.8×	67 0.9×	29 0.6×	16	477
Bihui Cao China	9	272 1.0×	107 0.6×	222 1.4×	110 1.5×	41 0.8×	19	536
Christian Seitz Germany	11	338 1.2×	246 1.5×	205 1.3×	55 0.8×	63 1.2×	40	663
Andressa S. Laino United States	11	382 1.4×	204 1.2×	273 1.7×	56 0.8×	28 0.5×	20	582
Jianqiu Wu China	12	263 0.9×	130 0.8×	114 0.7×	58 0.8×	35 0.7×	35	494
Kellie A. Mouchemore Australia	9	282 1.0×	137 0.8×	262 1.6×	74 1.0×	49 1.0×	10	535
Aditya Mohan United States	11	212 0.8×	137 0.8×	201 1.2×	43 0.6×	28 0.5×	26	414
Philippe De La Rochère France	6	206 0.7×	149 0.9×	202 1.2×	40 0.6×	37 0.7×	7	478

Countries citing papers authored by Ehsan Razeghian

Since Specialization

Citations

This map shows the geographic impact of Ehsan Razeghian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Razeghian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Razeghian more than expected).

Fields of papers citing papers by Ehsan Razeghian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Razeghian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Razeghian. The network helps show where Ehsan Razeghian may publish in the future.

Co-authorship network of co-authors of Ehsan Razeghian

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Razeghian. A scholar is included among the top collaborators of Ehsan Razeghian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Razeghian. Ehsan Razeghian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Razeghian, Ehsan, et al.. (2023). Recent advances in the application of genetic and epigenetic modalities in the improvement of antibody-producing cell lines. International Immunopharmacology. 123. 110724–110724. 1 indexed citations

2.

Razeghian, Ehsan, et al.. (2023). The Effects of Pifithrin-µ on Spermatogonial Stem Cell Viability and Pluripotency. Sexual Development. 17(4-6). 190–197. 1 indexed citations

3.

Hassanzadeh, Ali, et al.. (2023). Recent advances in mesenchymal stem/stromal cells (MSCs)‐based approaches for osteoarthritis (OA) therapy. Cell Biology International. 47(6). 1033–1048. 15 indexed citations

4.

Naimi, Adel, Rebar N. Mohammed, Ahmed Raji, et al.. (2022). Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Communication and Signaling. 20(1). 44–44. 306 indexed citations breakdown →

5.

Razeghian, Ehsan, et al.. (2022). The role of the natural killer (NK) cell modulation in breast cancer incidence and progress. Molecular Biology Reports. 49(11). 10935–10948. 13 indexed citations

6.

Razeghian, Ehsan, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, et al.. (2021). A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies. Stem Cell Research & Therapy. 12(1). 428–428. 91 indexed citations

7.

Razeghian, Ehsan, et al.. (2021). MSCs modifies the proliferation of leukemia MOLT-4 cells and induces their apoptosis through up-regulating Bax, caspase-3, and-8, and down-regulating Bcl-2 expression. Annals of Cancer Research and Therapy. 29(1). 79–84. 5 indexed citations

8.

Razeghian, Ehsan, et al.. (2021). Anti-leukemic effects of the quercetin on human leukemia U937 cells mediated by down-regulation of Mcl-1, survivin, and XIAP. Annals of Cancer Research and Therapy. 29(1). 55–61. 4 indexed citations

9.

Razeghian, Ehsan, Marwah Suliman Maashi, Abduladheem Turki Jalil, et al.. (2021). Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements. Stem Cells International. 2021. 1–11. 25 indexed citations

10.

Razeghian, Ehsan, et al.. (2020). Folic acid, vitamin B6 ,B12 and Breast cancer incidence. 5(18). 4–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact